Advanced in HIV/AIDS

Dr. Julia Garcia

Infectious Disease
Ochsner Clinic Foundation
1514 Jefferson Hwy, 
New Orleans, LA 
Advanced in HIV/AIDS
Ochsner Clinic Foundation
1514 Jefferson Hwy, 
New Orleans, LA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Julia Garcia is an Infectious Disease provider in New Orleans, Louisiana. Dr. Garcia is rated as an Advanced provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.

Her clinical research consists of co-authoring 38 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of HIV/AIDS.

Specialties
Infectious Disease
Licenses
Internal Medicine in LA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

Ochsner Clinic Foundation
1514 Jefferson Hwy, New Orleans, LA 70121
Call: 504-842-4005

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications
ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications
Enrollment Status: Completed
Publish Date: November 17, 2025
Intervention Type: Other, Drug
Study Drugs: Ivermectin, Fluvoxamine, Fluticasone
Study Phase: Phase 3
A Phase I/II, Observer-blind, Randomised, Placebo-controlled Study to Assess Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 64 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI)
A Phase I/II, Observer-blind, Randomised, Placebo-controlled Study to Assess Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 64 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI)
Enrollment Status: Completed
Publish Date: May 08, 2025
Intervention Type: Biological
Study Phase: Phase 2
A Phase IIIB, Randomized, Observer-blind, Multicenter Study to Assess the Safety and Immunogenicity of GSK's Meningococcal Group B Vaccine When Administered Concomitantly With GSK's Meningococcal MenACWY Conjugate Vaccine to Healthy Subjects of 16-18 Years of Age
A Phase IIIB, Randomized, Observer-blind, Multicenter Study to Assess the Safety and Immunogenicity of GSK's Meningococcal Group B Vaccine When Administered Concomitantly With GSK's Meningococcal MenACWY Conjugate Vaccine to Healthy Subjects of 16-18 Years of Age
Enrollment Status: Completed
Publish Date: March 04, 2025
Intervention Type: Combination product, Biological
Study Phase: Phase 3
A Phase 2 Study to Assess the Effect of a Repeated Dose of XF-73 Nasal Gel on the Microbiological Burden of Commensal Staphylococcus Aureus Nasal Carriage in Surgical Patients at Risk of Post-operative Staphylococcal Infections
A Phase 2 Study to Assess the Effect of a Repeated Dose of XF-73 Nasal Gel on the Microbiological Burden of Commensal Staphylococcus Aureus Nasal Carriage in Surgical Patients at Risk of Post-operative Staphylococcal Infections
Enrollment Status: Completed
Publish Date: October 16, 2023
Intervention Type: Drug
Study Phase: Phase 2
Assessment of Cognitive Ability and the Intestinal Microbiome in Individuals With Liver Disease Before and After Investigational Microbiota Restoration Therapeutic
Assessment of Cognitive Ability and the Intestinal Microbiome in Individuals With Liver Disease Before and After Investigational Microbiota Restoration Therapeutic
Enrollment Status: Terminated
Publish Date: October 03, 2023
Intervention Type: Biological
Study Drug: RBX7455
Study Phase: Phase 2
Randomized Master Protocol for Immune Modulators for Treating COVID-19
Randomized Master Protocol for Immune Modulators for Treating COVID-19
Enrollment Status: Completed
Publish Date: September 25, 2023
Intervention Type: Drug
Study Drugs: Infliximab, Abatacept, Remdesivir, Cenicriviroc
Study Phase: Phase 3
CONSORTIUM - A Double-Blind Placebo-Controlled Phase 2 Study of VE303 for Prevention of Recurrent Clostridium (Clostridioides) Difficile Infection
CONSORTIUM - A Double-Blind Placebo-Controlled Phase 2 Study of VE303 for Prevention of Recurrent Clostridium (Clostridioides) Difficile Infection
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Phase: Phase 2
Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Anti-CD14 Treatment in Hospitalized Patients With COVID-19
Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Anti-CD14 Treatment in Hospitalized Patients With COVID-19
Enrollment Status: Terminated
Publish Date: June 26, 2023
Intervention Type: Other, Drug, Biological
Study Drugs: Anti-CD14, Remdesivir
Study Phase: Phase 2
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of TJ003234 in Subjects With Severe Coronavirus Disease 2019 (COVID-19)
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of TJ003234 in Subjects With Severe Coronavirus Disease 2019 (COVID-19)
Enrollment Status: Completed
Publish Date: May 06, 2023
Intervention Type: Drug
Study Drug: TJ003234
Study Phase: Phase 2/Phase 3
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
Enrollment Status: Completed
Publish Date: November 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-controlled, Clinical Trial of LY3127804 in Patients Who Are Hospitalized With Pneumonia and Presumed or Confirmed COVID-19
A Randomized, Double-blind, Placebo-controlled, Clinical Trial of LY3127804 in Patients Who Are Hospitalized With Pneumonia and Presumed or Confirmed COVID-19
Enrollment Status: Terminated
Publish Date: August 12, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 10 Less Clinical Trials

38 Total Publications

Protocol for an international, multicentre, prospective, observational study of nosocomial pneumonia in intensive care units: the PneumoINSPIRE study.
Protocol for an international, multicentre, prospective, observational study of nosocomial pneumonia in intensive care units: the PneumoINSPIRE study.
Journal: Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine
Published: December 04, 2023
View All 38 Publications
Similar Doctors
Distinguished in HIV/AIDS
Dr. Michael E. Hagensee
Infectious Disease
Distinguished in HIV/AIDS
Dr. Michael E. Hagensee
Infectious Disease

Ochsner Medical Center - New Orleans

1514 Jefferson Hwy, 
New Orleans, LA 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances

Michael Hagensee is an Infectious Disease provider in New Orleans, Louisiana. Dr. Hagensee is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Distinguished in HIV/AIDS
Dr. Meredith E. Clement
Infectious Disease
Distinguished in HIV/AIDS
Dr. Meredith E. Clement
Infectious Disease

Louisiana State University School Of Medicine In New Orleans Faculty G

2000 Canal St, 
New Orleans, LA 
 (3.9 miles away)
504-702-3000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Meredith Clement is an Infectious Disease provider in New Orleans, Louisiana. Dr. Clement is rated as an Advanced provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Syphilis, Myelitis, and AIDS Dementia Complex. Dr. Clement is currently accepting new patients.

Distinguished in HIV/AIDS
Dr. Mary L. Eschete
Infectious Disease
Distinguished in HIV/AIDS
Dr. Mary L. Eschete
Infectious Disease

South Louisiana Medical Associates

1990 Industrial Boulevard, 
Houma, LA 
 (42.3 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mary Eschete is an Infectious Disease provider in Houma, Louisiana. Dr. Eschete is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are Myelitis, HIV/AIDS, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Eschete is currently accepting new patients.

VIEW MORE HIV/AIDS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Garcia's expertise for a condition
ConditionClose
      • Advanced
      • AIDS Dementia Complex
        Dr. Garcia is
        Advanced
        . Learn about AIDS Dementia Complex.
        See more AIDS Dementia Complex experts
      • AIDS Dysmorphic Syndrome
        Dr. Garcia is
        Advanced
        . Learn about AIDS Dysmorphic Syndrome.
        See more AIDS Dysmorphic Syndrome experts
      • HIV/AIDS
        Dr. Garcia is
        Advanced
        . Learn about HIV/AIDS.
        See more HIV/AIDS experts
      • Myelitis
        Dr. Garcia is
        Advanced
        . Learn about Myelitis.
        See more Myelitis experts
      • Pneumonia
        Dr. Garcia is
        Advanced
        . Learn about Pneumonia.
        See more Pneumonia experts
      • Severe Acute Respiratory Syndrome (SARS)
        Dr. Garcia is
        Advanced
        . Learn about Severe Acute Respiratory Syndrome (SARS).
        See more Severe Acute Respiratory Syndrome (SARS) experts
      • Experienced
      • Anthrax Infection
        Dr. Garcia is
        Experienced
        . Learn about Anthrax Infection.
        See more Anthrax Infection experts
      • Cellulitis
        Dr. Garcia is
        Experienced
        . Learn about Cellulitis.
        See more Cellulitis experts
      • COVID-19
        Dr. Garcia is
        Experienced
        . Learn about COVID-19.
        See more COVID-19 experts
      • Cryptococcosis
        Dr. Garcia is
        Experienced
        . Learn about Cryptococcosis.
        See more Cryptococcosis experts
      • Cytomegalic Inclusion Disease
        Dr. Garcia is
        Experienced
        . Learn about Cytomegalic Inclusion Disease.
        See more Cytomegalic Inclusion Disease experts
      • Cytomegalovirus Infection
        Dr. Garcia is
        Experienced
        . Learn about Cytomegalovirus Infection.
        See more Cytomegalovirus Infection experts
      View All 19 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.